Department of Chemical Engineering and ‡Koch Institute for Integrative Cancer Research, MIT , Cambridge, Massachusetts 02139, United States.
Mol Pharm. 2013 Oct 7;10(10):3531-43. doi: 10.1021/mp4003283. Epub 2013 Aug 26.
Early science fiction envisioned the future of drug delivery as targeted micrometer-scale submarines and "cyborg" body parts. Here we describe the progression of the field toward technologies that are now beginning to capture aspects of this early vision. Specifically, we focus on the two most prominent types of systems in drug delivery: the intravascular micro/nano drug carriers for delivery to the site of pathology and drug-loaded implantable devices that facilitate release with the predefined kinetics or in response to a specific cue. We discuss the unmet clinical needs that inspire these designs, the physiological factors that pose difficult challenges for their realization, and viable technologies that promise robust solutions. We also offer a perspective on where drug delivery may be in the next 50 years based on expected advances in material engineering and in the context of future diagnostics.
早期科幻小说设想药物输送的未来是靶向的微米级潜艇和“半机械人”身体部位。在这里,我们描述了该领域向现在开始捕捉早期愿景的技术的发展。具体来说,我们专注于药物输送中两种最突出的系统:用于递送到病变部位的血管内微/纳米药物载体和负载药物的可植入装置,这些装置可根据预设的动力学或响应特定提示促进药物释放。我们讨论了激发这些设计的未满足的临床需求、对其实现构成困难挑战的生理因素以及有前途的技术,这些技术有望提供可靠的解决方案。我们还根据材料工程的预期进展和未来诊断的背景,就药物输送在未来 50 年内可能的发展方向提供了一个观点。